From RNS4 Aug 2015 09:09
The Agreement formalises an already close technical relationship between the Company and Solvay's subsidiary Solvay Novecare, a world leader in specialty polymers and surfactants with an annual turnover in excess of Euro 2 billion. It is built upon the joint development of anti-microbials, combining the best of Byotrol's long-lasting anti-microbial formulations and Solvay's world-leading polymer and surfactant technologies (collectively the "Products"). The Company has already completed (and patented) one such product for the EU consumer market and is actively marketing it jointly with Solvay to customers.
Initially Byotrol will pool technical, commercial and sales resource with Solvay Novecare in targeting Products at the EU consumer market. Over time we expect to be expanding into other geographies, into professional markets and in due course into personal care markets too. The two parties will then be sharing gross profit from any jointly-developed products.